Form 4: AngioDynamics EVP and CFO Stephen Trowbridge Acquires 1,700 Shares
SEC Form 4
Stephen Trowbridge, EVP and CFO of AngioDynamics Inc., purchased 1,700 shares of common stock at $5.86 per share on October 8, 2024.
Summary
- On October 8, 2024, Stephen A. Trowbridge, the EVP and CFO of AngioDynamics Inc., acquired 1,700 shares of the company's common stock.
- The purchase price was $5.86 per share.
- Following the transaction, Trowbridge directly owns 172,711 shares of AngioDynamics Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. An executive purchasing shares suggests confidence, but it's a relatively small transaction.
Positives
- The purchase of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into a company's performance and future expectations. Purchases are generally viewed more positively than sales.
Stakeholder Impact
- The purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 10/08/2024 | Date of the transaction where Stephen A. Trowbridge purchased 1,700 shares of AngioDynamics Inc. common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.